封面
市场调查报告书
商品编码
1901522

马匹保健市场:依产品、适应症、用途、配销通路、国家及地区划分-全球产业分析、市场规模、市场占有率及2025-2032年预测

Equine Healthcare Market, By Product, By Indication, By Activity, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 365 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年马匹保健市场规模价值为 33.4567 亿美元,从 2025 年到 2032 年将以 8.4% 的复合年增长率成长。

马匹保健涵盖赛马、博彩马、骑乘马以及休閒马匹的各项服务。保健包括定期带马匹去兽医处接种疫苗、驱虫和进行牙齿护理。此外,还包括梳理毛髮、蹄部护理以及抵御恶劣天气(例如雨、风、雪)的保护。为了保持马匹终生健康,仅仅提供适当的饲料和运动是不够的。还需要进行其他一些日常护理。成年马每年至少应接受一次兽医的全面检查。 20岁以上的马每年至少应接受两次兽医检查,如果生病则应增加检查次数。这是因为老年马更容易生病,也更容易发现疾病。

马匹保健市场-市场动态

马术运动参与人​​数不断增加

随着越来越多的人参与骑马运动,马匹保健市场也受益于此趋势,更加重视马匹的健康和运动表现。由于越来越多的人参与赛马、盛装舞步和场地障碍赛等活动,对专业马匹保健用品和服务的需求也随之增长。越来越多的马术赛事和比赛要求参赛马匹制定全面的健康计划。这表明该趋势正在蓬勃发展。因此,随着马主将马匹的健康和运动表现放在首位,马匹保健市场预计将持续成长。根据英国马术协会统计,英国有182万名经常骑马者和320万名偶尔骑马者,马匹数量达85万匹,行业总值达66亿美元。

马匹保健市场細項分析:

全球市场按产品、适应症、活动、分销管道和地区进行细分。

根据产品类型,预计在预测期内,药品领域将占据最大的市场份额。市场成长的原因在于,人们对马匹的治疗性、预防性和特殊药物的需求不断增长。市场快速成长的原因在于,越来越多的马主了解马匹疾病,越来越多的人愿意接受兽医开立的治疗方案。抗生素、抗发炎药、止痛药和疫苗只是众多能够改善动物健康状况和提升其生活品质的手段中的一部分。领先的製药公司将研发、新型药物配方和巧妙的合作视为其发展马匹医疗保健业务的首要途径。由于生物製剂、再生疗法和个人化治疗方案不断改进,市场呈现细分收入成长的趋势。

根据相关数据,寄生虫感染领域在预测期内将占据市场主导地位。马匹体内外寄生虫的高发生率推动了市场成长。由于圆线虫、绦虫和蜱虫等寄生虫会导致严重的健康问题,例如腹痛、贫血和体重减轻,因此高效杀虫剂的需求仍然旺盛。为了提高用药的便利性和疗效,长效药物、合併疗法和改良配方正被越来越多地使用。

马匹保健市场—地理洞察

北美在2024年占据了大部分市场份额,并将在预测期内保持这一趋势。福利支出、骑乘马匹的普及以及诊断和再生疗法的进步都在推动该行业的成长。该地区日益完善的马匹健康和福利规章制度也有望促进其繁荣发展。美国农业部动植物卫生检验局(APHIS)于2024年5月加强了马匹保护条例,以阻止人们故意伤害马匹的行为。一些马主故意伤害马匹,以使其在赛马等活动中表现更佳,但这会对马匹的健康造成损害。

美国马匹医疗保健市场—国别分析

美国在该地区市场占据主导地位。这一发展趋势归因于多种因素,例如对先进兽药、诊断技术和软体服务的需求不断增长,以及马主、育种者和马术运动参与者对疾病的认识不断提高并采取措施预防疾病。此外,马医院收购数量的增加预计也将促进产业成长。例如,2025年4月,领先的国际马诊所网路Altano集团欣然宣布收购Del Oeste马医院。

目录

第一章:马匹医疗保健市场概览

  • 研究范围
  • 市场估算年份

第二章:执行概要

  • 市集
  • 竞争洞察

第三章:马匹医疗保健市场主要趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场未来趋势

第四章:马匹医疗保健产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 规范架构分析

第五章:马匹医疗保健市场:地缘政治紧张局势升级的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章:马匹医疗保健市场概况

  • 马匹保健市场占有率分析,2024 年
  • 主要製造商细分数据
    • 知名球员分析
    • 新兴参与者分析

第七章:马匹保健市场:依产品划分

  • 概述
    • 细分市场占有率分析:依产品
    • 製药
    • 疫苗
    • 药用饲料添加剂
    • 骨科生物製剂
    • 诊断
    • 软体与服务
    • 其他的

第八章:马匹保健市场:依适应症划分

  • 概述
    • 细分市场占有率分析:依指标
    • 马疱疹病毒
    • 肌肉骨骼疾病
    • 寄生虫感染
    • 马流感
    • 马病毒性动脉炎(EVA)
    • 破伤风
    • 西尼罗病毒
    • 其他的

第九章:马匹保健市场:依活动分类

  • 概述
    • 细分市场占有率分析:依活动划分
    • 运动/赛车
    • 娱乐
    • 其他的

第十章:马匹保健市场:依配销通路划分

  • 概述
    • 细分市场占有率分析:按配销通路划分
    • 兽医医院和诊所
    • 马术设施
    • 电子商务
    • 其他的

第十一章:马匹保健市场:依地域划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • その他
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • その他
  • 中东和非洲(MEA)
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • その他

第十二章:主要供应商分析:马匹医疗保健产业

  • 竞争格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Arthrex Inc.
    • Zoetis Services LLC
    • Cargill
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Heska Corporation
    • Merck & Co. Inc
    • Esaote SPA
    • Dechra
    • Covetrus Inc.
    • Elanco
    • IDEXX Laboratories, Inc.
    • Equine Care Group
    • Boehringer Ingelheim Animal Health USA Inc.
    • Merck Animal Health

第13章:全面展望

简介目录
Product Code: ANV5906

The equine healthcare Market size was valued at US$ 3,345.67 Million in 2024, expanding at a CAGR of 8.4% from 2025 to 2032.

Equine healthcare includes services for horses that race and wager, compete in riding, and have fun. Healthcare includes regular trips to the vet for vaccinations, parasite control, and dental care. It also includes grooming, hoof care, and protection from the elements, including rain, wind, and snow. To keep a horse healthy for life, it's necessary to do more than just feed and exercise it properly. One also needs to do other things that are part of general care. At least once a year, adult horses should see a veterinarian for a comprehensive check-up. Horses over the age of 20 should see their vet at least twice a year, and more often if they are unwell. This is because older animals are more likely to get sick, and it is easier to spot them.

Equine Healthcare Market- Market Dynamics

Rising participation in equestrian sports

As more people get into riding horses, the equine healthcare market has benefited from this trend by putting more focus on horse health and performance. Since more individuals get involved in activities like racing, dressage, and show jumping, the need for specialized healthcare supplies and services grows. An increasing number of equestrian events and competitions require full healthcare plans for the horses that take part. This shows how this trend is growing. Because of this, the equine healthcare market is predicted to rise as owners put the health and performance of their horses first. According to the British Equestrian, there are 1.82 million regular and 3.2 million occasional riders, 850,000 horses, and a USD 6.6 bn industry value.

Equine Healthcare Market- Segmentation Analysis:

The worldwide market is segmented on the basis of product, indication, activity, distribution Channel, and region.

Based on the product, the pharmaceuticals segment is expected to capture the largest market share over the projected period. The market is rising because there is more demand for therapeutic, preventative, and specialty medications for horses. The market is growing quickly because more horse owners are aware of equine diseases, more people are willing to accept treatments prescribed by veterinarians, and more people are willing to accept treatments prescribed by veterinarians. Antibiotics, anti-inflammatory medications, painkillers, and immunizations are just a few of the numerous things that can make animals healthier and help them do better. Leading pharmaceutical companies put research and development, novel medicine formulations, and clever collaborations at the top of their lists of ways to grow their equine healthcare businesses. The market is seeing segmented revenue growth because biologics, regenerative therapies, and personalized treatments are always getting better.

Based on the indication, the parasitic infections segment dominates the market over the projected period. The high frequency of internal and external parasites in horse's fuel market growth. Effective parasiticides are still in high demand since parasites like strongyles, tapeworms, and ticks can cause serious health issues like colic, anemia, and weight loss. Long-acting medications, combination therapy, and better formulations are increasingly being used to improve convenience and efficacy.

Equine Healthcare Market- Geographical Insights

North America captures the majority of the market share in 2024 and will continue the same pattern during the forecast period. Welfare expenditures, riding horses, and improvements in diagnostics and regenerative therapies are all helping the industry grow. The region's growing rules and regulations for horse health and welfare are also expected to help the region thrive. The Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) made the Horse Protection Regulations stronger in May 2024 to stop people from intentionally soring horses. Horse owners use this on purpose to injure their horses so they can do better in activities like racing, but it can be bad for the horse's health.

US Equine Healthcare Market- Country Insights

The US dominates the market in the region. This development is due to several causes, such as the expanding demand for advanced veterinary drugs, diagnostics, and software services, as well as horse owners, breeders, and equestrian sports participants being more aware of and taking steps to prevent problems. Furthermore, the growing acquisition of equine hospitals is expected to foster industry growth. For instance, in April 2025, Altano Group, a leading international network of equine clinics at the forefront of veterinary medicine, is thrilled to announce its acquisition of Del Oeste Equine Hospital.

Equine Healthcare Market- Competitive Landscape:

The market is rising because there is a growing need for therapeutic, preventative, and specialty drugs for horses. The market is developing swiftly because more horse owners know about horse diseases, more people are prepared to follow the advice of veterinarians, and more horses are getting sick. Antibiotics, anti-inflammatory medications, painkillers, and immunizations are just a few of the things that can help animals be healthier and do better. Top pharmaceutical companies put research and development, novel treatment formulations, and clever collaborations at the top of their lists to grow their equine healthcare businesses. The market is seeing segmented revenue growth because biologics, regenerative therapies, and tailored treatments are continually improving.

Recent Developments:

In March 2025, Altano Group, an internationally renowned network of leading equine veterinary clinics, announced a strategic partnership with Idaho Equine Hospital, a leading provider of western performance horse medicine and veterinary education. This collaboration further strengthens Altano's commitment to advancing equine healthcare globally.

In February 2025, in an exciting development within the equine veterinary community, Altano Group, an international leader in equine veterinary medicine, announced that Performance Equine Associates, a renowned full-service equine hospital and ambulatory practice located in Thackerville, Oklahoma, near the Texas state border, has joined the Altano Group.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EQUINE HEALTHCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arthrex Inc.
  • Zoetis Services LLC
  • Cargill
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Heska Corporation
  • Merck & Co. Inc
  • Esaote SPA
  • Dechra
  • Covetrus Inc.
  • Elanco
  • IDEXX Laboratories, Inc.
  • Equine Care Group
  • Boehringer Ingelheim Animal Health USA Inc.
  • Merck Animal Health

GLOBAL EQUINE HEALTHCARE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals
  • Vaccines
  • Medicinal Feed Additives
  • Orthobiologics
  • Diagnostics
  • Software & Services
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Equine Herpes Virus
  • Musculoskeletal Disorders
  • Parasitic Infections
  • Equine Influenza
  • Equine Viral Arteritis (EVA)
  • Tetanus
  • West Nile Virus
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY ACTIVITY- MARKET ANALYSIS, 2019 - 2032

  • Sports/Racing
  • Recreation
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Hospitals & Clinics
  • Equestrian Facilities
  • E-commerce
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Equine Healthcare Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Equine Healthcare Market Snippet by Product
    • 2.1.2. Equine Healthcare Market Snippet by Indication
    • 2.1.3. Equine Healthcare Market Snippet by Activity
    • 2.1.4. Equine Healthcare Market Snippet by Distribution Channel
    • 2.1.5. Equine Healthcare Market Snippet by Country
    • 2.1.6. Equine Healthcare Market Snippet by Region
  • 2.2. Competitive Insights

3. Equine Healthcare Key Market Trends

  • 3.1. Equine Healthcare Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Equine Healthcare Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Equine Healthcare Market Opportunities
  • 3.4. Equine Healthcare Market Future Trends

4. Equine Healthcare Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Equine Healthcare Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Equine Healthcare Market Landscape

  • 6.1. Equine Healthcare Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Equine Healthcare Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Pharmaceuticals
    • 7.1.3. Vaccines
    • 7.1.4. Medicinal Feed Additives
    • 7.1.5. Orthobiologics
    • 7.1.6. Diagnostics
    • 7.1.7. Software & Services
    • 7.1.8. Others

8. Equine Healthcare Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024&2032 (%)
    • 8.1.2. Equine Herpes Virus
    • 8.1.3. Musculoskeletal Disorders
    • 8.1.4. Parasitic Infections
    • 8.1.5. Equine Influenza
    • 8.1.6. Equine Viral Arteritis (EVA)
    • 8.1.7. Tetanus
    • 8.1.8. West Nile Virus
    • 8.1.9. Others

9. Equine Healthcare Market - By Activity

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Activity, 2024&2032 (%)
    • 9.1.2. Sports/Racing
    • 9.1.3. Recreation
    • 9.1.4. Others

10. Equine Healthcare Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2024&2032 (%)
    • 10.1.2. Veterinary Hospitals & Clinics
    • 10.1.3. Equestrian Facilities
    • 10.1.4. E-commerce
    • 10.1.5. Others

11. Equine Healthcare Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Equine Healthcare Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.2.6. North America Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.2.8.5. U.S. Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.2.9.5. Canada Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Equine HealthcareKey Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.3.6. Europe Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.8.5. Germany Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.9.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.9.5. UK Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.10.5. France Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.11.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.11.5. Italy Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.12.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.12.5. Spain Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.13.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.14.5. Sweden Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.15.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.15.5. Russia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.16.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.16.5. Poland Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Equine HealthcareKey Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.4.6. APAC Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.8.5. China Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.9.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.9.5. India Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.10.5. Japan Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.11.5. South Korea Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.12.5. Australia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.14.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.14.5. Thailand Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.15.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.15.5. Philippines Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Equine Healthcare Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.5.6. LATAM Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.8.5. Brazil Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.9.5. Mexico Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.10.5. Argentina Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.11.5. Colombia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Equine HealthcareKey Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.6.6. MEA Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.9. UAE
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.9.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.9.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.9.5. UAE Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.9.6. UAE Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.10.5. Israel Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.11.5. Turkey Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.12.5. Algeria Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.13.5. Egypt Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)

12. Key Vendor Analysis- Equine Healthcare Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arthrex Inc.
    • 12.2.2. Zoetis Services LLC
    • 12.2.3. Cargill
    • 12.2.4. Boehringer Ingelheim International GmbH
    • 12.2.5. Ceva Sante Animale
    • 12.2.6. Heska Corporation
    • 12.2.7. Merck & Co. Inc
    • 12.2.8. Esaote SPA
    • 12.2.9. Dechra
    • 12.2.10. Covetrus Inc.
    • 12.2.11. Elanco
    • 12.2.12. IDEXX Laboratories, Inc.
    • 12.2.13. Equine Care Group
    • 12.2.14. Boehringer Ingelheim Animal Health USA Inc.
    • 12.2.15. Merck Animal Health

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us